Trastuzumab deruxtecan (T-DXd, DS-8201) in HER2-positive metastatic breast cancer previously treated with T-DM1: DESTINY-Breast01 Study

Krop, I; Manich, CS; Yamashita, T; Park, YH; Kim, SBK; Tamura, K; Andre, F; Iwata, H; Ito, Y; Tsurutani, J; Sohn, J; Denduluri, N; Perrin, C; Aogi, K; Tokunaga, E; Im, SA; Lee, KS; Hurvitz, S; Cortes, J; Lee, C; Chen, S; Zhang, L; Shahidi, J; Yver, A; Modi, S

SWISS MEDICAL WEEKLY, 2020; (): 25S

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索